Aims and scope

Advancement in Medicinal Plant Research is a peer-reviewed open access journal, which publishes ground-breaking work from all areas of medicinal plant research. It covers from plant growth and development, agronomic management, plant nutrition, plant physiology, cell biology, molecular biology, biotechnology, medicinal properties, phytochemical constituents, fitoterapia, pharmacognosy, essential oils, ehnopharmacology and phytomedicine.

Open Access

All articles published by Advancement in Medicinal Plant Research are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers.

Authors of articles published in Advancement in Medicinal Plant Research are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the Net Journals copyright and license agreement.

Article-processing charges

Open access publishing is not without costs. Advancement in Medicinal Plant Research therefore levies an article-processing charge of $400 for each article accepted for publication. We routinely waive charges for authors from low-income countries. A limited number of waivers for article-processing charges are also available at the editors' discretion, and authors wishing to apply for these waivers should contact the editors.

Publication and peer review process

Content overview

Advancement in Medicinal Plant Research considers the following types of articles:

• Regular articles: These should describe new and carefully confirmed findings, and experimental procedures should be given in sufficient detail for others to verify the work. The length of a full paper should be the minimum required to describe and interpret the work clearly.

• Reviews: Submissions of reviews and perspectives covering topics of current interest are welcome and encouraged. Reviews should be concise and no longer than 4-6 printed pages (about 12 to 18 manuscript pages). Reviews manuscripts are also peer-reviewed.

• Short Communications: A Short Communication is suitable for recording the results of complete small investigations or giving details of new models or hypotheses, innovative methods, techniques or apparatus. The style of main sections need not conform to that of full-length papers. Short communications are 2 to 4 printed pages (about 6 to 12 manuscript pages) in length.

Ethical guidelines

Submission of a manuscript to Advancement in Medicinal Plant Research implies that all authors have read and agreed to its content, and that any experimental research that is reported in the manuscript has been performed with the approval of an appropriate ethics committee. Advancement in Medicinal Plant Research's publisher, Net Journals, has a legal responsibility to ensure that its journals do not publish material that infringes copyright, or that includes libellous or defamatory content. If, on review, your manuscript is perceived to contain potentially libellous content the journal Editors, with assistance from the publisher if required, will work with authors to ensure an appropriate outcome is reached. The involvement of scientific writers or anyone else who assisted with the preparation of the manuscript content should be acknowledged.

Data and materials release

Submission of a manuscript to Advancement in Medicinal Plant Research implies that readily reproducible materials described in the manuscript, including all relevant raw data, will be freely available to any scientist wishing to use them for non-commercial purposes. Nucleic acid sequences, protein sequences, and atomic coordinates should be deposited in an appropriate database in time for the accession number to be included in the published article. In computational studies where the sequence information is unacceptable for inclusion in databases because of lack of experimental validation, the sequences must be published as an additional file with the article. Any 'in press' articles cited within the references and necessary for the reviewers' assessment of the manuscript should be made available if requested by the editorial office.

Competing interests

Advancement in Medicinal Plant Research requires authors to declare any competing financial or other interest in relation to their work. All competing interests that are declared will be listed at the end of published articles. Where an author gives no competing interests, the listing will read 'The author(s) declare that they have no competing interests'.

Plagiarism detection

In cases of suspected plagiarism CrossCheck is available to the editors of Advancement in Medicinal Plant Research to detect instances of overlapping and similar text in submitted manuscripts. CrossCheck is a multi-publisher initiative allowing screening of published and submitted content for originality.

Copyright

Authors of articles published in Advancement in Medicinal Plant Research retain the copyright of their articles and are free to reproduce and disseminate their work.